Af­ter three-month de­lay, Am­gen’s Lumakras clinch­es FDA green light in col­orec­tal can­cer

Am­gen’s Lumakras has se­cured an FDA ap­proval in com­bi­na­tion with the drug­mak­er’s Vectibix for a sub­set of pa­tients with metasta­t­ic col­orec­tal can­cer, mark­ing a pos­i­tive …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER